1 |
Abatacept
| 2件: ABATACEPT ABATACEPT; ORENCIA | 1件: Abatacept
Abatacept
💬 | 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
2 |
Acetaminophen
| 4件: Acetaminophen Acetaminophen; Paracetamol; Tylenol; Ultracet | 1件: Acetaminophen
Acetaminophen
💬 | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 15件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬 |
3 |
Aluminium
| 2件: Aluminium Aluminium; Aluminum | - | - | - | 2件: 11 11, 46 💬 |
4 |
Aluminum hydroxide
| 2件: Aluminium hydroxide Aluminium hydroxide; Aluminum hydroxide | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 2件: 11 11, 46 💬 |
5 |
Amifampridine
| 2件: Amifampridine Amifampridine; Firdapse | 1件: Amifampridine
Amifampridine
💬 | 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 💬 |
6 |
Apraclonidine
| 1件: Apraclonidine Apraclonidine | 1件: Apraclonidine
Apraclonidine
💬 | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
7 |
Azathioprine
| 3件: Azathioprine Azathioprine; AZATIOPRINA; Imuran | 1件: Azathioprine
Azathioprine
💬 | - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬 |
8 |
Batoclimab
| 1件: Batoclimab Batoclimab | 1件: Batoclimab
Batoclimab
💬 | 1件: FCGRT FCGRT 💬 | - | 2件: 11 11, 14 💬 |
9 |
Belimumab
| 2件: Belimumab Belimumab; Benlysta | 1件: Belimumab
Belimumab
💬 | 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬 |
10 |
Bortezomib
| 3件: BORTEZOMIB BORTEZOMIB; Bortezomib Accord; Velcade | 1件: Bortezomib
Bortezomib
💬 | 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬 |
11 |
Bortezomib D-mannitol
| 3件: BORTEZOMIB BORTEZOMIB; Bortezomib D-mannitol; Velcade | - | - | - | 3件: 11 11, 28, 61 💬 |
12 |
Carmustine
| 1件: Carmustine Carmustine | 1件: Carmustine
Carmustine
💬 | - | - | 5件: 11 11, 13, 14, 28, 60 💬 |
13 |
Cemdisiran
| 1件: CEMDISIRAN CEMDISIRAN | - | - | - | 4件: 11 11, 62, 66, 109 💬 |
14 |
Chloride ion
| 1件: Chloride Chloride | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬 |
15 |
Cladribine
| 4件: 2-CdA 2-CdA; CLADRIBINA; Cladribine; MAVENCLAD | 1件: Cladribine
Cladribine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 11 11, 13, 94 💬 |
16 |
Coenzyme M
| 2件: MESNA MESNA; UROMITEXAN | - | - | - | 10件: 11 11, 13, 44, 45, 51, 60, 65, 85, 96, 164 💬 |
17 |
Corynebacterium diphtheriae
| 1件: Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | 1件: 11 11 💬 |
18 |
Corynebacterium diphtheriae CRM197 protein
| 1件: CRM197 CRM197 | - | - | - | 3件: 11 11, 13, 46 💬 |
19 |
CV-MG01
| 1件: CV-MG01 CV-MG01 | - | - | - | 1件: 11 11 💬 |
20 |
Cyclophosphamide
| 6件: Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; CYCLOPHOSPHAMIDE; Cyclophosphamidum; Cytoxan | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬 |
21 |
Cyclosporine
| 10件: CICLOSPORIN CICLOSPORIN; CICLOSPORINA; Ciclosporine; Cyclosporin; Cyclosporin A; Cyclosporine; Cyclosporine A; Ikervis; Neoral; RESTASIS | 1件: Cyclosporine
Cyclosporine
💬 | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
22 |
Cytarabine
| 1件: Cytarabine Cytarabine | 1件: Cytarabine
Cytarabine
💬 | - | - | 7件: 11 11, 13, 14, 25, 49, 60, 65 💬 |
23 |
Diphenhydramine
| 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride | 1件: Diphenhydramine
Diphenhydramine
💬 | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 8件: 11 11, 13, 49, 51, 70, 86, 222, 256 💬 |
24 |
Eculizumab
| 2件: ECULIZUMAB ECULIZUMAB; Soliris | 1件: Eculizumab
Eculizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 11 11, 13, 14, 61, 62, 109, 222 💬 |
25 |
Efalizumab
| 2件: EFALIZUMAB EFALIZUMAB; Raptiva | 1件: Efalizumab
Efalizumab
💬 | 1件: ITGAL ITGAL 💬 | 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 9件: 11 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
26 |
Efgartigimod alfa
| 1件: EFGARTIGIMOD ALFA EFGARTIGIMOD ALFA | 1件: Efgartigimod alfa
Efgartigimod alfa
💬 | 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 35, 53, 63, 162 💬 |
27 |
Ephedrine
| 3件: Efedrina Efedrina; Ephedrine; EPHEDRINE HYDROCHLORIDE | 1件: Ephedrine
Ephedrine
💬 | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
28 |
Etoposide
| 1件: Etoposide Etoposide | 1件: Etoposide
Etoposide
💬 | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
29 |
Famciclovir
| 1件: Famciclovir Famciclovir | 1件: Famciclovir
Famciclovir
💬 | - | - | 2件: 11 11, 13 💬 |
30 |
Filgrastim
| 7件: FILGRASTIM FILGRASTIM; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio | 1件: Filgrastim
Filgrastim
💬 | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 35件: 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
31 |
Fludarabine
| 4件: FLUDARA FLUDARA; FLUDARABINA; Fludarabine; Fludarabine Phosphate | 1件: Fludarabine
Fludarabine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 20件: 11 11, 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 💬 |
32 |
Human immunoglobulin G
| 19件: Bivigam Bivigam; CUTAQUIG; CUVITRU; GAMMAGARD LIQUID; Gammaplex; GAMUNEX-C; Hizentra; Human immunoglobulin G; Human normal immunoglobulin; HyQvia; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; IVIG; KIOVIG; OCTAGAM; PANZYGA; PRIVIGEN; Vivaglobin | - | - | - | 10件: 11 11, 13, 14, 17, 43, 45, 50, 51, 63, 65 💬 |
33 |
Hydroxide ion
| 2件: Example Example; Hydroxide | - | - | - | 6件: 5 5, 11, 46, 96, 97, 284 💬 |
34 |
Inebilizumab
| 2件: Inebilizumab Inebilizumab; Uplizna | 1件: Inebilizumab
Inebilizumab
💬 | 1件: CD19 CD19 💬 | 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 4件: 11 11, 13, 51, 300 💬 |
35 |
Iron polymaltose
| 1件: Fusion Fusion | - | - | - | 9件: 11 11, 13, 46, 49, 69, 70, 86, 271, 299 💬 |
36 |
Isoxaflutole
| 1件: Balance Balance | - | - | - | 5件: 6 6, 11, 46, 81, 149 💬 |
37 |
Lactobacillus casei
| 2件: Fusion Fusion; Lactobacillus casei | 1件: Lactobacillus casei
Lactobacillus casei
💬 | - | - | 10件: 6 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 💬 |
38 |
Leflunomide
| 3件: ARAVA ARAVA; Leflunomide; Leflunomidum | 1件: Leflunomide
Leflunomide
💬 | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 12件: 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 💬 |
39 |
Magnesium
| 1件: Magnesium Magnesium | - | - | - | 19件: 6 6, 11, 13, 46, 51, 63, 64, 70, 93, 97, 111, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
40 |
Magnesium sulfate
| 1件: Magnesium sulfate Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
💬 | - | - | 3件: 11 11, 296, 297 💬 |
41 |
Melphalan
| 3件: ALKERAN ALKERAN; MELPHALAN; Melphalan Hydrochloride | 1件: Melphalan
Melphalan
💬 | - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
42 |
Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine
| 1件: Menveo Menveo | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
43 |
Meningococcal polysaccharide vaccine group A
| 2件: Menveo Menveo; Nimenrix | 1件: Meningococcal polysaccharide vaccine group A
Meningococcal polysaccharide vaccine group A
💬 | - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 💬 |
44 |
Meningococcal polysaccharide vaccine group C
| 2件: Menveo Menveo; Nimenrix | 1件: Meningococcal polysaccharide vaccine group C
Meningococcal polysaccharide vaccine group C
💬 | - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 💬 |
45 |
Meningococcal polysaccharide vaccine group W-135
| 2件: MENVEO MENVEO; Nimenrix | - | - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 💬 |
46 |
Meningococcal polysaccharide vaccine group Y
| 2件: Menveo Menveo; Nimenrix | - | - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 💬 |
47 |
Methamidophos
| 1件: MONITOR MONITOR | - | - | - | 4件: 2 2, 11, 81, 129 💬 |
48 |
Methotrexate
| 6件: Methotrexat Methotrexat; Methotrexate; METHOTREXATE SODIUM; METOJECT; Metotrexato; Méthotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
49 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE | 1件: Methylprednisolone
Methylprednisolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
50 |
Monarsen
| 1件: MONARSEN MONARSEN | - | - | - | 1件: 11 11 💬 |
51 |
Mycophenolate mofetil
| 3件: CELLCEPT CELLCEPT; Mycophenolate mofetil; Mycophenolate mofetil TEVA | 1件: Mycophenolate mofetil
Mycophenolate mofetil
💬 | 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
52 |
Mycophenolic acid
| 5件: Acido Micofenolico Acido Micofenolico; MICOFENOLICO ACIDO; Mycophenolate; Mycophenolic Acid; Myfortic | 1件: Mycophenolic acid
Mycophenolic acid
💬 | 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
53 |
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: Menveo Menveo | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
54 |
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: Menveo Menveo | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
55 |
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: Menveo Menveo | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
56 |
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: MENVEO MENVEO | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
57 |
Neisseria meningitidis serogroup b fhbp fusion protein antigen
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
58 |
Neisseria meningitidis serogroup b nada protein antigen
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
59 |
Neisseria meningitidis serogroup b nhba fusion protein antigen
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
60 |
Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 💬 |
61 |
Nipocalimab
| 1件: Nipocalimab Nipocalimab | 1件: Nipocalimab
Nipocalimab
💬 | 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 46, 49, 53, 61 💬 |
62 |
Oxaloacetic acid
| 1件: Oxaloacetate Oxaloacetate | - | - | - | 2件: 6 6, 11 💬 |
63 |
Phosphate ion
| 1件: Phosphate Phosphate | - | - | - | 32件: 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬 |
64 |
Pixantrone
| 1件: PIXANTRONE PIXANTRONE | 1件: Pixantrone
Pixantrone
💬 | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 2件: 11 11, 13 💬 |
65 |
Pozelimab
| 1件: Pozelimab Pozelimab | 1件: Pozelimab
Pozelimab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 11 11, 62 💬 |
66 |
Prednisolone
| 3件: Prednisolona Prednisolona; PREDNISOLONE; Prednisolonum | 1件: Prednisolone
Prednisolone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
67 |
Prednisone
| 3件: Prednisona Prednisona; PREDNISONE; RAYOS | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
68 |
Pyridostigmine
| 3件: Mestinon Mestinon; PYRIDOSTIGMINE; Pyridostigmine Bromide | - | - | - | 4件: 3 3, 6, 11, 256 💬 |
69 |
Rabbit
| 1件: Rabbit Rabbit | - | - | - | 8件: 11 11, 13, 49, 51, 60, 65, 96, 285 💬 |
70 |
Ravulizumab
| 2件: Ravulizumab Ravulizumab; Ultomiris | 1件: Ravulizumab
Ravulizumab
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬 |
71 |
Resiniferatoxin
| 0件: | - | - | - | 5件: 11 11, 46, 65, 222, 240 💬 |
72 |
Rituximab
| 6件: MabThera MabThera; Rituxan; Rituximab; Rixathon; Ruxience; TRUXIMA | 1件: Rituximab
Rituximab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
73 |
Rozanolixizumab
| 1件: ROZANOLIXIZUMAB ROZANOLIXIZUMAB | 1件: Rozanolixizumab
Rozanolixizumab
💬 | 1件: FCGRT FCGRT 💬 | - | 3件: 11 11, 14, 63 💬 |
74 |
Salbutamol
| 3件: Albuterol Albuterol; Salbutamol; Ventolin | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬 |
75 |
Satralizumab
| 3件: Enspryng Enspryng; Sapelizumab; Satralizumab | 1件: Satralizumab
Satralizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 11 11, 13, 86 💬 |
76 |
Sodium chloride
| 6件: Lactated Ringers Lactated Ringers; Natriumchlorid; REBIF; Saline; Sodium chloride; SPORANOX | 1件: Sodium chloride
Sodium chloride
💬 | - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
77 |
Sulfate ion
| 1件: Sulfate Sulfate | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬 |
78 |
Tacrolimus
| 2件: Prograf Prograf; Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬 | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
79 |
Tocilizumab
| 3件: ACTEMRA ACTEMRA; ROACTEMRA; TOCILIZUMAB | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
80 |
Tofacitinib
| 4件: Tasocitinib Tasocitinib; TOFACITINIB; XELJANZ; Xeljanz XR | 1件: Tofacitinib
Tofacitinib
💬 | 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 |
81 |
Zilucoplan
| 1件: Zilucoplan Zilucoplan | 1件: Zilucoplan
Zilucoplan
💬 | 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 2 2, 11, 62 💬 |